Target haemoglobin in the treatment of anaemia of chronic renal failure by recombinant human erythropoietin

Influence of recombinant human erythropoietin therapy on plasma level of insulin-like growth factor type 1 (IGF-1) in chronic hemodialysis patients.

Poor response to recombinant erythropoietin is associated with altered interleukin-10 production

Effect of recombinant human erythropoietin on the parathyroid function and bone density in uremic patients under regular hemodialysis

CD28 T-lymphocytes as a marker of chronic inflammation in hemodialysis patients showing poor response to erythropoietin therapy

Study of the influence of erythropoietin treatment on hemoglobin Alc levels in diabetic patients with chronic renal failure on hemodialysis

Endothelial function in end-stage renal disease (ESRD) and dialysis patients; possible role of erythropoietin hormone treatment in experimental animals

Diagnostic value of reticulocyte hemoglobincontent in hemodialysis patients receiving recombinant human erythropoietin

Diagnostic value of reticulocyte hemoglobincontent in hemodialysis patients receiving recombinant human erythropoietin

Anaemia of chronic renal failure : New perspectives